Finally, Shao et al. have evaluated the effect of anti-PD-L1 antibody in combination with the CUR natural analogue bisdemethoxycurcumin (BDMC) in an in vivo mouse model of bladder cancer, a type of neoplasia known to express PD-L1. This evidence concerns the gene CD274 and urinary bladder cancer.